90288 Botulism ig intravenous
Also known as: BIG-IV, botulism IG, botulism immunoglobulin
Botulism immunoglobulin intravenous for passive immunotherapy of botulism in pediatric patients.
In Plain Language
infant botulism treatment; immune globulin for botulism
Clinical Context
FDA-approved immunotherapeutic for infantile botulism caused by Clostridium botulinum toxin, administered intravenously to bind and neutralize toxin.
RVU Information
CPT 90288 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Medicine section codes cover a wide range of non-surgical services. Documentation should include the clinical indication, procedure details, interpretation (if applicable), and any patient-specific findings.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Medicine category, 34% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 90288?
CPT 90288 (Botulism ig intravenous) is a Medicine code. Botulism immunoglobulin intravenous for passive immunotherapy of botulism in pediatric patients.
Who uses CPT code 90288?
CPT 90288 is used by Infectious Disease, Pediatrics, Critical Care. FDA-approved immunotherapeutic for infantile botulism caused by Clostridium botulinum toxin, administered intravenously to bind and neutralize toxin.
When is CPT 90288 used?
FDA-approved immunotherapeutic for infantile botulism caused by Clostridium botulinum toxin, administered intravenously to bind and neutralize toxin.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.